cladribine has been researched along with Skin Neoplasms in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (60.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Lallas, A; Papadopoulou, A; Papazisis, G; Rigas, A; Stamatellos, VP; Stamoula, E | 1 |
Ergene, U; Işisağ, A; Ozbalcı, D | 1 |
Biernat, W; Jeziorski, A; Krykowski, E; Robak, E; Robak, T | 1 |
Bosly, A; Brousset, P; Delannoy, A; Pris, J; Riga-Huguet, F; Schlaifer, D | 1 |
Hurria, A; Kuzel, TM; Rademaker, AW; Roenigk, HH; Rosen, ST; Samuelson, E; Tallman, MS | 1 |
Piro, LD | 1 |
Kong, LR; Kuzel, TM; Rademaker, AW; Roenigk, HH; Rosen, ST; Samuelson, E; Tallman, MS | 1 |
Hönigsmann, H; Knobler, RM; Schwarzmeier, J; Trautinger, F | 1 |
Bouwhuis, SA; el-Azhary, RA; Gibson, LE; Habermann, TM; McEvoy, MT; Pittelkow, MR; Witzig, TE | 1 |
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Saven, A | 1 |
1 review(s) available for cladribine and Skin Neoplasms
Article | Year |
---|---|
Cladribine in the treatment of low-grade non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Skin Neoplasms; Waldenstrom Macroglobulinemia | 1996 |
3 trial(s) available for cladribine and Skin Neoplasms
Article | Year |
---|---|
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Marrow Diseases; Cladribine; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Opportunistic Infections; Sezary Syndrome; Skin Neoplasms; Treatment Outcome | 1996 |
2-Chlorodeoxyadenosine in cutaneous T-cell lymphoproliferative disorders.
Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoproliferative Disorders; Male; Middle Aged; Prognosis; Skin Neoplasms; Survival Rate | 1997 |
Low-dose 2-chlorodeoxyadenosine for the treatment of mycosis fungoides.
Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Skin Neoplasms | 1999 |
6 other study(ies) available for cladribine and Skin Neoplasms
Article | Year |
---|---|
S1P receptor modulators in Multiple Sclerosis: Detecting a potential skin cancer safety signal.
Topics: Cladribine; Humans; Immunosuppressive Agents; Multiple Sclerosis; Skin Neoplasms; Sphingosine 1 Phosphate Receptor Modulators | 2022 |
Hairy Cell Leukemia and cutaneous involvement.
Topics: Antigens, CD; Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Male; Skin Neoplasms | 2012 |
Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Carcinoma, Merkel Cell; Cladribine; Female; Humans; Immunosuppressive Agents; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Metastasis; Middle Aged; Remission Induction; Rituximab; Skin Neoplasms; Treatment Outcome | 2005 |
Secondary neoplasms in two patients treated with purine analogues.
Topics: Acute Disease; Aged; Cladribine; Female; Humans; Immunocompromised Host; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melanoma; Neoplasms, Second Primary; Skin Neoplasms; Vidarabine; Waldenstrom Macroglobulinemia | 1994 |
Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Humans; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Retrospective Studies; Sezary Syndrome; Skin Neoplasms; Survival Rate | 2002 |
2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.
Topics: 2-Chloroadenosine; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Agents; Cladribine; Deoxyadenosines; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Skin Neoplasms; Time Factors | 1992 |